nodes	percent_of_prediction	percent_of_DWPC	metapath
Ergoloid mesylate—CYP3A4—breast cancer	0.36	1	CbGaD
Ergoloid mesylate—CYP3A4—Exemestane—breast cancer	0.0754	0.133	CbGbCtD
Ergoloid mesylate—CYP3A4—Letrozole—breast cancer	0.0641	0.113	CbGbCtD
Ergoloid mesylate—CYP3A4—Anastrozole—breast cancer	0.0572	0.101	CbGbCtD
Ergoloid mesylate—CYP3A4—Toremifene—breast cancer	0.0523	0.0921	CbGbCtD
Ergoloid mesylate—CYP3A4—Fulvestrant—breast cancer	0.0486	0.0856	CbGbCtD
Ergoloid mesylate—CYP3A4—Thiotepa—breast cancer	0.0433	0.0763	CbGbCtD
Ergoloid mesylate—CYP3A4—Ixabepilone—breast cancer	0.0396	0.0698	CbGbCtD
Ergoloid mesylate—CYP3A4—Lapatinib—breast cancer	0.0381	0.0672	CbGbCtD
Ergoloid mesylate—CYP3A4—Raloxifene—breast cancer	0.0289	0.0509	CbGbCtD
Ergoloid mesylate—CYP3A4—Vinorelbine—breast cancer	0.0212	0.0373	CbGbCtD
Ergoloid mesylate—CYP3A4—Tamoxifen—breast cancer	0.0191	0.0336	CbGbCtD
Ergoloid mesylate—CYP3A4—Mitoxantrone—breast cancer	0.0186	0.0328	CbGbCtD
Ergoloid mesylate—CYP3A4—Paclitaxel—breast cancer	0.0149	0.0262	CbGbCtD
Ergoloid mesylate—CYP3A4—Irinotecan—breast cancer	0.0147	0.0258	CbGbCtD
Ergoloid mesylate—CYP3A4—Vinblastine—breast cancer	0.013	0.023	CbGbCtD
Ergoloid mesylate—CYP3A4—Docetaxel—breast cancer	0.0107	0.0189	CbGbCtD
Ergoloid mesylate—CYP3A4—Doxorubicin—breast cancer	0.00801	0.0141	CbGbCtD
Ergoloid mesylate—Dihydroergotamine—CYP3A4—breast cancer	0.000823	0.271	CrCbGaD
Ergoloid mesylate—Dihydroergotamine—ABCB1—breast cancer	0.000685	0.226	CrCbGaD
Ergoloid mesylate—Ergotamine—CYP3A4—breast cancer	0.000424	0.14	CrCbGaD
Ergoloid mesylate—Bromocriptine—CYP3A4—breast cancer	0.000409	0.135	CrCbGaD
Ergoloid mesylate—Ergotamine—ABCB1—breast cancer	0.000353	0.116	CrCbGaD
Ergoloid mesylate—Bromocriptine—ABCB1—breast cancer	0.00034	0.112	CrCbGaD
Ergoloid mesylate—DRD1—Signaling Pathways—PLA2G4A—breast cancer	1.54e-05	0.000223	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—CXCR4—breast cancer	1.54e-05	0.000223	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—CXCL12—breast cancer	1.54e-05	0.000223	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—CSF2—breast cancer	1.52e-05	0.000221	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—FGF1—breast cancer	1.52e-05	0.000221	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling by GPCR—RAF1—breast cancer	1.52e-05	0.00022	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—NRG1—breast cancer	1.51e-05	0.000219	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—PAK1—breast cancer	1.51e-05	0.000218	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—H2AFX—breast cancer	1.5e-05	0.000218	CbGpPWpGaD
Ergoloid mesylate—DRD1—GPCR downstream signaling—IL2—breast cancer	1.5e-05	0.000218	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—E2F1—breast cancer	1.49e-05	0.000216	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—HADHB—breast cancer	1.49e-05	0.000215	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—GPI—breast cancer	1.49e-05	0.000215	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling by GPCR—PIK3CB—breast cancer	1.48e-05	0.000215	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—TCF7L2—breast cancer	1.48e-05	0.000215	CbGpPWpGaD
Ergoloid mesylate—DRD2—GPCR downstream signaling—AKT2—breast cancer	1.47e-05	0.000214	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling by GPCR—PIK3CG—breast cancer	1.46e-05	0.000212	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—SPP1—breast cancer	1.43e-05	0.000208	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—HSP90AA1—breast cancer	1.43e-05	0.000207	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—NOTCH2—breast cancer	1.43e-05	0.000207	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling by GPCR—CXCL8—breast cancer	1.43e-05	0.000207	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—ALDH7A1—breast cancer	1.42e-05	0.000206	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—ALDH1A1—breast cancer	1.42e-05	0.000206	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—ERBB3—breast cancer	1.42e-05	0.000205	CbGpPWpGaD
Ergoloid mesylate—DRD2—GPCR downstream signaling—PIK3CD—breast cancer	1.42e-05	0.000205	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—FGFR2—breast cancer	1.41e-05	0.000205	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—PRL—breast cancer	1.39e-05	0.000201	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—AGTR1—breast cancer	1.39e-05	0.000201	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—STK11—breast cancer	1.37e-05	0.000198	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—ADAM10—breast cancer	1.37e-05	0.000198	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling by GPCR—IL2—breast cancer	1.36e-05	0.000198	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—FHL2—breast cancer	1.36e-05	0.000197	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—NME1—breast cancer	1.36e-05	0.000197	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—PHGDH—breast cancer	1.36e-05	0.000197	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—ADSL—breast cancer	1.36e-05	0.000197	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—UMPS—breast cancer	1.36e-05	0.000197	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—TERT—breast cancer	1.36e-05	0.000197	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—PLG—breast cancer	1.35e-05	0.000196	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling by GPCR—AKT2—breast cancer	1.34e-05	0.000194	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—HPSE—breast cancer	1.33e-05	0.000193	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—BRIP1—breast cancer	1.33e-05	0.000193	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—LDHB—breast cancer	1.33e-05	0.000193	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—FGF10—breast cancer	1.33e-05	0.000193	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—FGFR1—breast cancer	1.32e-05	0.000191	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—HIF1A—breast cancer	1.3e-05	0.000188	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling by GPCR—PIK3CD—breast cancer	1.29e-05	0.000186	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—PDGFA—breast cancer	1.28e-05	0.000186	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—LEP—breast cancer	1.27e-05	0.000184	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—TGFBR2—breast cancer	1.27e-05	0.000184	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—GSTA3—breast cancer	1.26e-05	0.000183	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—HMMR—breast cancer	1.26e-05	0.000183	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—ABCC1—breast cancer	1.26e-05	0.000183	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—CAV1—breast cancer	1.26e-05	0.000182	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—ITPR1—breast cancer	1.25e-05	0.000181	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—KDR—breast cancer	1.24e-05	0.00018	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—ERBB4—breast cancer	1.24e-05	0.000179	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—MMP3—breast cancer	1.24e-05	0.000179	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—STAT5A—breast cancer	1.24e-05	0.000179	CbGpPWpGaD
Ergoloid mesylate—DRD2—GPCR downstream signaling—PIK3CB—breast cancer	1.23e-05	0.000179	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—PPARGC1B—breast cancer	1.22e-05	0.000177	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—ESR1—breast cancer	1.21e-05	0.000175	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—SMAD4—breast cancer	1.2e-05	0.000174	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—FN1—breast cancer	1.2e-05	0.000173	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—IGF1R—breast cancer	1.19e-05	0.000173	CbGpPWpGaD
Ergoloid mesylate—DRD2—GPCR downstream signaling—CXCL8—breast cancer	1.19e-05	0.000172	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—NFKBIA—breast cancer	1.18e-05	0.000171	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—HES1—breast cancer	1.17e-05	0.00017	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—NOTCH1—breast cancer	1.17e-05	0.00017	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—PLA2G4A—breast cancer	1.16e-05	0.000169	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—NCOR1—breast cancer	1.16e-05	0.000169	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—CA9—breast cancer	1.16e-05	0.000168	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—GSTA4—breast cancer	1.16e-05	0.000168	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—FGF1—breast cancer	1.15e-05	0.000167	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—CSF2—breast cancer	1.15e-05	0.000167	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling by GPCR—RAF1—breast cancer	1.15e-05	0.000166	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—APC—breast cancer	1.14e-05	0.000166	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—PIK3CG—breast cancer	1.14e-05	0.000166	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—KIT—breast cancer	1.14e-05	0.000166	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—NRG1—breast cancer	1.14e-05	0.000166	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—H2AFX—breast cancer	1.13e-05	0.000164	CbGpPWpGaD
Ergoloid mesylate—DRD2—GPCR downstream signaling—IL2—breast cancer	1.13e-05	0.000164	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—EGF—breast cancer	1.13e-05	0.000164	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—GSTA2—breast cancer	1.13e-05	0.000163	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—GPX2—breast cancer	1.13e-05	0.000163	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—E2F1—breast cancer	1.13e-05	0.000163	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling by GPCR—PIK3CB—breast cancer	1.12e-05	0.000162	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—SULT1A1—breast cancer	1.11e-05	0.000161	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—GPX4—breast cancer	1.11e-05	0.000161	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling by GPCR—MAPK3—breast cancer	1.1e-05	0.000159	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—IDH1—breast cancer	1.09e-05	0.000158	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—GSTA1—breast cancer	1.09e-05	0.000158	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—SPP1—breast cancer	1.08e-05	0.000157	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling by GPCR—CXCL8—breast cancer	1.08e-05	0.000156	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—BRAF—breast cancer	1.08e-05	0.000156	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—NAT2—breast cancer	1.07e-05	0.000156	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—ERBB3—breast cancer	1.07e-05	0.000155	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—FGFR2—breast cancer	1.07e-05	0.000155	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—IGF1—breast cancer	1.05e-05	0.000152	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—AKT2—breast cancer	1.05e-05	0.000152	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling by GPCR—EGFR—breast cancer	1.04e-05	0.000151	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling by GPCR—IL2—breast cancer	1.03e-05	0.000149	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—TERT—breast cancer	1.03e-05	0.000149	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—PIK3CD—breast cancer	1.01e-05	0.000146	CbGpPWpGaD
Ergoloid mesylate—DRD1—GPCR downstream signaling—PIK3CA—breast cancer	9.96e-06	0.000144	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—FGFR1—breast cancer	9.96e-06	0.000144	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—SERPINE1—breast cancer	9.95e-06	0.000144	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling by GPCR—KRAS—breast cancer	9.85e-06	0.000143	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—HIF1A—breast cancer	9.81e-06	0.000142	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—LEP—breast cancer	9.57e-06	0.000139	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—NOS3—breast cancer	9.5e-06	0.000138	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—CAV1—breast cancer	9.48e-06	0.000137	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—MED12—breast cancer	9.42e-06	0.000137	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—DPYD—breast cancer	9.42e-06	0.000137	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—KDR—breast cancer	9.38e-06	0.000136	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—ALDOA—breast cancer	9.27e-06	0.000134	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—ESR1—breast cancer	9.14e-06	0.000132	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling by GPCR—PIK3CA—breast cancer	9.05e-06	0.000131	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—FN1—breast cancer	9.03e-06	0.000131	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—MDM2—breast cancer	9.01e-06	0.000131	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—NCOA3—breast cancer	9e-06	0.000131	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—RAF1—breast cancer	8.98e-06	0.00013	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—RELA—breast cancer	8.94e-06	0.00013	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—SLC2A2—breast cancer	8.94e-06	0.00013	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—NFKBIA—breast cancer	8.92e-06	0.000129	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—ERBB2—breast cancer	8.88e-06	0.000129	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—NOTCH1—breast cancer	8.83e-06	0.000128	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—MTOR—breast cancer	8.77e-06	0.000127	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—PIK3CB—breast cancer	8.77e-06	0.000127	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—CPT1A—breast cancer	8.76e-06	0.000127	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—ABCG2—breast cancer	8.76e-06	0.000127	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—MTR—breast cancer	8.76e-06	0.000127	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—APC—breast cancer	8.64e-06	0.000125	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—PIK3CG—breast cancer	8.64e-06	0.000125	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—KIT—breast cancer	8.64e-06	0.000125	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—HPGDS—breast cancer	8.59e-06	0.000125	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—EGF—breast cancer	8.54e-06	0.000124	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—HBA1—breast cancer	8.54e-06	0.000124	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—CXCL8—breast cancer	8.43e-06	0.000122	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling by GPCR—HRAS—breast cancer	8.37e-06	0.000121	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—GSTT1—breast cancer	8.33e-06	0.000121	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—ACHE—breast cancer	8.33e-06	0.000121	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling by GPCR—MAPK3—breast cancer	8.27e-06	0.00012	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—CDKN1B—breast cancer	8.23e-06	0.000119	CbGpPWpGaD
Ergoloid mesylate—DRD1—GPCR downstream signaling—AKT1—breast cancer	8.14e-06	0.000118	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—BRAF—breast cancer	8.12e-06	0.000118	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—CASP3—breast cancer	8.06e-06	0.000117	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—IL2—breast cancer	8.05e-06	0.000117	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling by GPCR—IL6—breast cancer	8.01e-06	0.000116	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—IGF1—breast cancer	7.91e-06	0.000115	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—AKT2—breast cancer	7.9e-06	0.000115	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—CYP17A1—breast cancer	7.89e-06	0.000114	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling by GPCR—EGFR—breast cancer	7.87e-06	0.000114	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—CCND1—breast cancer	7.85e-06	0.000114	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—JUN—breast cancer	7.83e-06	0.000114	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—ENO1—breast cancer	7.81e-06	0.000113	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—PTGS1—breast cancer	7.81e-06	0.000113	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—CTNNB1—breast cancer	7.77e-06	0.000113	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—CYP2D6—breast cancer	7.66e-06	0.000111	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—MMP9—breast cancer	7.62e-06	0.00011	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—PIK3CD—breast cancer	7.59e-06	0.00011	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—CDKN1A—breast cancer	7.59e-06	0.00011	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—PTEN—breast cancer	7.58e-06	0.00011	CbGpPWpGaD
Ergoloid mesylate—DRD2—GPCR downstream signaling—PIK3CA—breast cancer	7.52e-06	0.000109	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—NCOA2—breast cancer	7.51e-06	0.000109	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—SERPINE1—breast cancer	7.51e-06	0.000109	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling by GPCR—KRAS—breast cancer	7.44e-06	0.000108	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—MAPK8—breast cancer	7.41e-06	0.000107	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling by GPCR—AKT1—breast cancer	7.39e-06	0.000107	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—FASN—breast cancer	7.29e-06	0.000106	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—BCHE—breast cancer	7.26e-06	0.000105	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—NOS3—breast cancer	7.17e-06	0.000104	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—SLC5A5—breast cancer	7.17e-06	0.000104	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—SRC—breast cancer	7.03e-06	0.000102	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—NQO1—breast cancer	6.92e-06	0.0001	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—SLC2A1—breast cancer	6.92e-06	0.0001	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—VEGFA—breast cancer	6.84e-06	9.92e-05	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling by GPCR—PIK3CA—breast cancer	6.83e-06	9.9e-05	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—MDM2—breast cancer	6.8e-06	9.86e-05	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—RAF1—breast cancer	6.78e-06	9.83e-05	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—STAT3—breast cancer	6.78e-06	9.82e-05	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—RELA—breast cancer	6.75e-06	9.79e-05	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—ERBB2—breast cancer	6.71e-06	9.72e-05	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—CYP1B1—breast cancer	6.64e-06	9.62e-05	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—PIK3CB—breast cancer	6.62e-06	9.6e-05	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—MTOR—breast cancer	6.62e-06	9.6e-05	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—HSP90AA1—breast cancer	6.51e-06	9.44e-05	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—MAPK3—breast cancer	6.47e-06	9.38e-05	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—CXCL8—breast cancer	6.36e-06	9.22e-05	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—NCOA1—breast cancer	6.33e-06	9.18e-05	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling by GPCR—HRAS—breast cancer	6.32e-06	9.16e-05	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—MYC—breast cancer	6.3e-06	9.13e-05	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—TGFB1—breast cancer	6.28e-06	9.1e-05	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—STK11—breast cancer	6.24e-06	9.05e-05	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—CYP19A1—breast cancer	6.24e-06	9.05e-05	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—CDKN1B—breast cancer	6.21e-06	9.01e-05	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—EGFR—breast cancer	6.16e-06	8.93e-05	CbGpPWpGaD
Ergoloid mesylate—DRD2—GPCR downstream signaling—AKT1—breast cancer	6.15e-06	8.91e-05	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—CASP3—breast cancer	6.09e-06	8.83e-05	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—IL2—breast cancer	6.08e-06	8.81e-05	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling by GPCR—IL6—breast cancer	6.05e-06	8.77e-05	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—CCND1—breast cancer	5.93e-06	8.59e-05	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—JUN—breast cancer	5.91e-06	8.57e-05	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—CTNNB1—breast cancer	5.87e-06	8.51e-05	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—KRAS—breast cancer	5.82e-06	8.43e-05	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—COMT—breast cancer	5.8e-06	8.41e-05	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—GSTP1—breast cancer	5.77e-06	8.37e-05	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—MMP9—breast cancer	5.75e-06	8.34e-05	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—CDKN1A—breast cancer	5.73e-06	8.31e-05	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—PTEN—breast cancer	5.72e-06	8.29e-05	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—HMOX1—breast cancer	5.7e-06	8.26e-05	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—ITPR1—breast cancer	5.68e-06	8.24e-05	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—MAPK8—breast cancer	5.6e-06	8.11e-05	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling by GPCR—AKT1—breast cancer	5.58e-06	8.09e-05	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—ABCB1—breast cancer	5.47e-06	7.92e-05	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—TYMS—breast cancer	5.37e-06	7.78e-05	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—PIK3CA—breast cancer	5.34e-06	7.75e-05	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—NCOR1—breast cancer	5.31e-06	7.69e-05	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—GSTM1—breast cancer	5.31e-06	7.69e-05	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—PLA2G4A—breast cancer	5.31e-06	7.69e-05	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—SRC—breast cancer	5.3e-06	7.69e-05	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—TP53—breast cancer	5.17e-06	7.5e-05	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—VEGFA—breast cancer	5.17e-06	7.49e-05	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—STAT3—breast cancer	5.12e-06	7.42e-05	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—GPX1—breast cancer	5.08e-06	7.37e-05	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—CYP1A1—breast cancer	5.03e-06	7.29e-05	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—ERCC2—breast cancer	4.99e-06	7.23e-05	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—HRAS—breast cancer	4.95e-06	7.17e-05	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—MAPK3—breast cancer	4.89e-06	7.08e-05	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—MYC—breast cancer	4.75e-06	6.89e-05	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—TGFB1—breast cancer	4.74e-06	6.87e-05	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—IL6—breast cancer	4.73e-06	6.86e-05	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—MTHFR—breast cancer	4.69e-06	6.8e-05	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—EGFR—breast cancer	4.65e-06	6.74e-05	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—KRAS—breast cancer	4.39e-06	6.37e-05	CbGpPWpGaD
Ergoloid mesylate—DRD1—Signaling Pathways—AKT1—breast cancer	4.37e-06	6.33e-05	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—CAV1—breast cancer	4.33e-06	6.27e-05	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—PIK3CA—breast cancer	4.04e-06	5.85e-05	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—PIK3CG—breast cancer	3.94e-06	5.71e-05	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—TP53—breast cancer	3.9e-06	5.66e-05	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—HRAS—breast cancer	3.73e-06	5.41e-05	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—IL6—breast cancer	3.57e-06	5.18e-05	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—PIK3CD—breast cancer	3.46e-06	5.02e-05	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—ALB—breast cancer	3.42e-06	4.96e-05	CbGpPWpGaD
Ergoloid mesylate—DRD2—Signaling Pathways—AKT1—breast cancer	3.3e-06	4.78e-05	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—NOS3—breast cancer	3.27e-06	4.74e-05	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—PIK3CB—breast cancer	3.02e-06	4.38e-05	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—PTGS2—breast cancer	2.99e-06	4.34e-05	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—PTEN—breast cancer	2.61e-06	3.78e-05	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—PIK3CA—breast cancer	1.84e-06	2.67e-05	CbGpPWpGaD
Ergoloid mesylate—CYP3A4—Metabolism—AKT1—breast cancer	1.5e-06	2.18e-05	CbGpPWpGaD
